Detalhe da pesquisa
1.
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
J Oncol Pharm Pract;
29(8): 1806-1815, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35903919
2.
Topical chlormethine gel in the treatment of mycosis fungoides: A single-center real-life experience and systematic review of the literature.
Dermatol Ther;
35(9): e15683, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35778940
3.
COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors.
Neurol Sci;
43(6): 3519-3522, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35397014
4.
Ensuring retention in care for people living with HIV during the COVID-19 pandemic in Rome, Italy.
Sex Transm Infect;
97(4): 317, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33046581
5.
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.
Front Immunol;
14: 1221587, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38343436
6.
[Immunotherapy with nivolumab and pembrolizumab in unresectable or metastatic advanced melanoma: real-life observational study of drug use.] / Immunoterapia con nivolumab e pembrolizumab nel melanoma in fase avanzata non resecabile o metastatico: studio osservazionale in real-life di farmacoutilizzazione.
Recenti Prog Med;
112(12): 792-801, 2021 12.
Artigo
em Italiano
| MEDLINE
| ID: mdl-34924574
7.
The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey.
Eur J Cancer;
153: 260-264, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34183225
8.
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia.
J Hematol Oncol;
14(1): 119, 2021 07 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34325728
9.
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.
J Hematol Oncol;
14(1): 81, 2021 05 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34001183
10.
Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution.
Clin Cancer Res;
27(24): 6815-6823, 2021 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34583970
11.
Clinical and Immunological Outcomes in High-Risk Resected Melanoma Patients Receiving Peptide-Based Vaccination and Interferon Alpha, With or Without Dacarbazine Preconditioning: A Phase II Study.
Front Oncol;
10: 202, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32211314
12.
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas.
Leukemia;
36(2): 588-590, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34545184